Skip to Content

'
Judy Un Chong Ahrar, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Assistant Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler Street
Unit Number: 1471
Houston, TX 77030
Room Number: FCT14.5094
Fax: 713-792-4098
Email: judy.ahrar@mdanderson.org

Education & Training

Degree-Granting Education

2000 University of Miami, Miami, FL, MD, Medicine
1996 University of Miami, Coral Gables, FL, BS, Cum Laude, Biology

Postgraduate Training

2005-2006 Clinical Fellowship, Interventional Radiology, The University of Texas Medical School at Houston, Houston, TX
2001-2005 Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center, Houston, TX
2000-2001 Clinical Internship, Internal Medicine, New Hanover Regional Medical Center, Wilmington, NC

Board Certifications

11/2007 American Board of Radiology, Vascular and Interventional Radiology
6/2005 American Board of Radiology

Experience/Service

Academic Appointments

Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2012-9/2013

Administrative Appointments/Responsibilities

Professional Quality Committee Physician Liaison, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007-present

Honors and Awards

1994-2000 University of Miami Honors Program in Medicine, University of Miami
1994-1996 Challenger Astronaut Scholarship
1994-1996 Florida Undergraduate Scholarship
1994-1996 Henry King Stanford Academic Scholarship

Professional Memberships

American College of Radiology, Reston, VA
Member, 1/2007-present
American Medical Association, Chicago, IL
Member, 9/1996-12/2000
Texas Medical Association, Austin, TX
Member, 9/2001-present
Texas Radiological Society, Austin, TX
Member, 1/2007-present
Western Angiographic and Interventional Society, Oakland, CA
Member, 1/2007-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Ahrar K, Ahrar JU, Javadi S, Pan L, Milton DR, Wood CG, Matin SF, Stafford RJ. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Invest Radiol 48(6):437-44, 6/2013. e-Pub 3/2013. PMCID: PMC3899798.
2. Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. Magnetic resonance imaging-guided biopsy in the musculoskeletal system using a cylindrical 1.5-T magnetic resonance imaging unit. Top Magn Reson Imaging 22(4):189-96, 8/2011. PMID: 23514926.
3. Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 1/2011. PMID: 21166498.
4. Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, 10/2010. e-Pub 11/2009. PMID: 19935383.
5. Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 21(5):690-695, 5/2010. e-Pub 3/2010. PMID: 20227295.
6. Ahrar K, Gowda A, Javadi S, Borne A, Fox M, McNichols R, Ahrar JU, Stephens C, Stafford RJ. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J Vasc Interv Radiol 21(4):555-561, 4/2010. PMCID: PMC2847585.
7. Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 11/2004. PMID: 15525755.

Abstracts

1. Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. MRI-guided biiopsy in the musculoskeletal system using a cylindrical 1.5-T MRI unit. Global Academic Programs, 4/2013.
2. Alzubaidi S,Ahrar JU, Javadi S, Gupta S, Stafford RJ, Ahrar K. MRI-guided biopsy using a cylindrical high-field-strength magnet: experience with 303 biopsies in 294 patients. J Vasc Interv Radiol Supplement 24(4S):S96 (#204), 4/2013.
3. Ahrar K, Ahrar JU, Javadi S, Pan L, Milton D, Wood CG, Matin SF, Stafford RJ. Real-time MRI guided cryoablation of small renal tumors at 1.5 tesla. Global Academic Programs, 4/2013.
4. Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam A, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae S, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: a large single-center study. J Vasc Interv Radiol Supplement 23(3S):S27-S28 (#60), 3/2012.
5. Javadi J, Ahrar JU, Ninan E, Gupta S, Matin S, Ahrar K. Characterization of contrast enhancement in the ablation zone immediatley after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 21(5):690-695, May, 5/2010.
6. Javadi S, Ahrar JU, Stafford RJ, Bock M, Jenna JW, Ahrar K. MRI-guided tumor ablation at high magnetic field: technologies, devices, advantages and limitations. J Vasc Interv Radiol 20(2):S114 (#303), 2009.
7. Javadi S, Stafford RJ, Ahrar JU, Gupta S, Wallace MJ, Pan L, Ahrar K. Real-time MR-guided percutaneous interventions in a dedicated 1.5T clinical suite. Proc Intl Soc Mag Reson Med 17:2554, 2009.
8. Javadi S, Ahrar JU, Ninan EP, Gupta S, Matin SF, Ahrar K. Renal tumors continue to accummulate iodinated contrast in the immediate post-RFA period. J Vasc Interv Radiol 20(2):S8 (#16), 2009.
9. Ahrar JU, Javadi S, Valenzuela Y, Gupta S, Stafford R, Ahrar K. MRI guided biopsy using a high field strength magnet: Initial experience with 95 patients. 94th Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2008.
10. Javadi S, Ahrar JU, Gupta S, Wallace MJ, Matin SF, Ahrar K. Embolotherapy in the management of patients with renal cell carcinoma: Current indications, technical considerations, and complications. 93rd Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2007.
11. Javadi S, Stafford RJ, Ahrar JU, Gowda A, McNichols R, Ahrar K. Principles of laser induced thermal therapy. 93rd Radiological Society of North America Scientific Assembly and Annual Meeting Program, 2007.
12. Ahrar JU, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ. Response and survival after hepatic artery chemoembolization in patients with melanomas metastatic to the liver. J Vasc Interv Radiol 18(1):S57, 2007.
13. Himmerich JU, Ahrar K, Wang S, Gupta S, Raymond A, Herzog C. Utility of ultrasound-guided percutaneous biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15:S231, 2004.
14. Himmerich JU, Ahrar K, Gupta S, Wallace MJ, Madoff DC, Morello FA. Intra-arterial chemotherapy for osteosarcoma: Indications, technique, and complications. Radiology 229:763, 2003.

Book Chapters

1. Ahrar JU, Javadi S, Ahrar K. Percutaneous and Transjugular Kidney Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media: New Yrok, NY, 2013.
2. Ahrar K, Javadi S, Ahrar JU,. Renal Mass Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media: New York, NY, 2013.
3. Ahrar JU, Ahrar K. Ultrasound-Guided Biopsy. In: Percutaneous Image-Guided Biopsy. Springer Science+Business Media: New York, NY, 2013.

Manuals, Teaching Aids, Other Teaching Publications

1. Himmerich JU, Ahrar K. Palliation of bone and soft tissue tumors with RFA. Interventional Oncology: Current practice and future trends. Manual for Conference sponsored by the Society of Interventional Radiology: San Francisco, CA, 2003.

Grant & Contract Support

Title: Phase 1b, esclating dose study of AVL-292, a Bruton's Tyrosine Kimase (BtK) inhibitor, as monotherapy subjects with relapsed and/or refractory B cell non-hodgkin lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia.
Funding Source: Celgene Corporation
Role: Collaborator
Principal Investigator: Jan Burger, M.D.
Duration: 2011 - present
 
Title: A phase 1b open-label, expansion study to investigate the safety, efficacy, and pharmacokinetics of intravenous CUDC-101 in subjects with advanced head and neck, gastric, breast, and liver tumors.
Funding Source: Curis, Inc
Role: Collaborator
Principal Investigator: Siging Fu, M.D.
Duration: 2010 - present
 
Title: A study to determine correlation of MR thermal imaging to actual size of ablation during laser therapy of soft tissue metastases to bone.
Funding Source: BioTex, Inc.
Role: Collaborator
Principal Investigator: Kamran Ahrar, M.D.
Duration: 2008 - 4/30/2012
 
Title: A phase I/II, open label, multi-centre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the Tor Kinase inhibitors AZD8055 administered orally to patients with advanced solid tumors, lymphomas and endometrial carcinoma.
Funding Source: AstraZeneca
Role: Collaborator
Principal Investigator: Aung Naing, M.D.
Duration: 2008 - 2011
 
Title: Enhanced T-cell immunity to novel breast cancer antigens.
Funding Source: Susan G. Komen Breast Cancer Foundation
Role: Collaborator
Principal Investigator: James Murray, M.D.
Duration: 2006 - present
 
Title: A phase II study of SGN-30 in combination with CHOP in anaplastic large cell lymphoma.
Funding Source: SAIC-Frederick, Inc.
Role: Collaborator
Principal Investigator: Michelle A. Fanale, M.D.
Duration: 2006 - 2011

Last updated: 7/2/2014